Notices. DEPARTMENT OF HEALTH AND HUMAN SERVICES
407 words·~2 min read·
/register/2013/01/28/2013-01649A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4160-70-M DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Committee on Immunization Practices
(ACIP)In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention
(CDC)announce the following meeting of the aforementioned committee: Times and Dates 8:00 a.m.-5:00 p.m., February 20, 2013, 8:00 a.m.-3:00 p.m., February 21, 2013. *Place:* CDC, Tom Harkin Global Communications Center, 1600 Clifton Road, NE., Building 19, Kent “Oz” Nelson Auditorium, Atlanta, Georgia 30333. *Status:* Open to the public, limited only by the space available. *Purpose:* The committee is charged with advising the Director, CDC, on the appropriate uses of immunizing agents. In addition, under 42 U.S.C. 1396s, the committee is mandated to establish and periodically review and, as appropriate, revise the list of vaccines for administration to vaccine-eligible children through the Vaccines for Children
(VFC)program, along with schedules regarding the appropriate periodicity, dosage, and contraindications applicable to the vaccines. Further, under provisions of the Affordable Care Act, at section 2713 of the Public Health Service Act, immunization recommendations of the ACIP that have been adopted by the Director of the Centers for Disease Control and Prevention must be covered by applicable health plans. *Matters To Be Discussed:* The agenda will include discussions on: adult immunization, general recommendations, 13-valent pneumococcal conjugate vaccine, influenza, Japanese encephalitis vaccine, pertussis, *Haemophilus influenzae* b
(Hib)vaccine, smallpox and vaccine supply. Recommendation votes are scheduled for Hib vaccine, influenza and 13-valent pneumococcal conjugate vaccine. VFC votes are scheduled for *Haemophilus influenzae* b
(Hib)vaccine and 13-valent pneumococcal conjugate vaccine. Time will be available for public comment. Agenda items are subject to change as priorities dictate. *Contact Person for More Information:* Stephanie B. Thomas, National Center for Immunization and Respiratory Diseases, CDC, 1600 Clifton Road, NE., MS-A27, Atlanta, Georgia 30333, Telephone:
(404)639-8836; Email *ACIP@CDC.GOV.* Meeting is Web cast live via the World Wide Web; for instructions and more information on ACIP please visit the ACIP Web site: *http://www.cdc.gov/vaccines/acip/index.html.* The Director, Management Analysis and Services Office, has been delegated the authority to sign **Federal Register** notices pertaining to announcements of meetings and other committee management activities for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: January 22, 2013. Dana Redford, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2013-01649 Filed 1-25-13; 8:45 am]
Connectionstraces to 1
Traces to 1 document
1 reference not yet in our index
- Pub. L. 92-463
Citation graph
cites case law
Cites 2Cited by 0 across 0 sources